Scynexis Inc. (SCYX) NASDAQ

$2.87 0.16 (5.90%)

Market Cap: $93.50M

As of 08/12/22 04:00 PM EDT. Market closed.

(SCYX)

Scynexis Inc. (SCYX) NASDAQ

$2.87 0.16 (5.90%)

Market Cap: $93.50M

As of 08/12/22 04:00 PM EDT. Market closed.

SCYNEXIS, Inc. is a biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant. Its lead candidate, ibrexafungerp (formerly known as SCY-078), is a broad-spectrum, IV/oral antifungal agent representing a novel therapeutic class. It is currently under review by the FDA ... read more

SCYNEXIS, Inc. is a biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant. Its lead candidate, ibrexafungerp (formerly known as SCY-078), is a broad-spectrum, IV/oral antifungal agent representing a novel therapeutic class. It is currently under review by the FDA as a treatment for vaginal yeast infections and in late-stage development for multiple life-threatening fungal infections in hospitalized patients. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
1 Evertrust Plz Fl 13, New Jersey, Jersey City, 07302-3051.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
38
Address
1 Evertrust Plz Fl 13, New Jersey, Jersey City, 07302-3051.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$2.81
Previous Close
$2.71
Days Range
$2.72 - $2.90
52 week range
$1.70 - $8.10
Volume
105,710
Avg. Volume (30 days)
157,839
Market Cap
$93.50M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
32,579,491
Open
$2.81
Previous Close
$2.71
Days Range
$2.72 - $2.90
52 week range
$1.70 - $8.10
Volume
105,710
Avg. Volume (30 days)
157,839
Market Cap
$93.50M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
32,579,491

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SCYNEXIS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Taglietti Marco Chief Executive Officer Apr 26, 2022 Buy $3.00 75,000 225,000 272,068 Apr 28, 2022, 07:25 AM
Sukenick Scott General Counsel Apr 26, 2022 Buy $3.00 3,500 10,500 53,499 Apr 28, 2022, 07:24 AM
PERCEPTIVE ADVISORS LLC 10% Owner Jan 22, 2021 Sale $8.24 319,000 2,629,781 1,833,849 Jan 26, 2021, 09:57 PM
PERCEPTIVE ADVISORS LLC 10% Owner Jan 21, 2021 Sale $7.38 95,000 701,100 2,120,000 Jan 26, 2021, 09:57 PM
PERCEPTIVE ADVISORS LLC 10% Owner Jan 20, 2021 Sale $7.43 185,000 1,374,550 2,215,000 Jan 26, 2021, 09:57 PM
Tinmouth Brian Philippe Director Dec 21, 2020 Buy $6.25 8,000 50,000 8,000 Dec 23, 2020, 09:12 AM
Taglietti Marco Chief Executive Officer Dec 21, 2020 Buy $6.25 40,000 250,000 109,668 Dec 23, 2020, 09:10 AM
Sukenick Scott General Counsel Dec 21, 2020 Buy $6.25 1,600 10,000 9,099 Dec 23, 2020, 09:10 AM
Macdonald Guy Director Dec 21, 2020 Buy $6.25 8,000 50,000 12,000 Dec 23, 2020, 09:09 AM
HANHAM ANN Director Dec 21, 2020 Buy $6.25 3,200 20,000 3,622 Dec 23, 2020, 09:07 AM
GILMAN STEVEN C Director Dec 21, 2020 Buy $6.25 4,000 25,000 4,000 Dec 23, 2020, 09:06 AM
Francois Eric Chief Financial Officer Dec 21, 2020 Buy $6.25 600 3,750 11,732 Dec 23, 2020, 09:05 AM
ANIDO ARMANDO Director Dec 21, 2020 Buy $6.25 5,000 31,250 5,000 Dec 23, 2020, 09:02 AM
Angulo Gonzalez David Chief Medical Officer Dec 21, 2020 Buy $6.25 1,600 10,000 23,780 Dec 23, 2020, 09:00 AM
Sukenick Scott General Counsel Nov 25, 2020 Option Exercise $6.81 2,613 17,795 7,499 Dec 04, 2020, 09:00 PM
Sukenick Scott General Counsel Feb 15, 2020 Option Exercise $9.80 783 7,673 9,912 Dec 04, 2020, 09:00 PM
Francois Eric Chief Financial Officer Nov 25, 2020 Option Exercise $6.81 3,480 23,699 11,132 Dec 04, 2020, 08:59 PM
Francois Eric Chief Financial Officer Feb 15, 2020 Option Exercise $9.80 979 9,594 14,412 Dec 04, 2020, 08:59 PM
Angulo Gonzalez David Chief Medical Officer Nov 25, 2020 Option Exercise $6.81 4,323 29,440 22,180 Dec 04, 2020, 08:57 PM
Angulo Gonzalez David Chief Medical Officer Feb 15, 2020 Option Exercise $9.80 1,175 11,515 26,303 Dec 04, 2020, 08:57 PM
Taglietti Marco Chief Executive Officer Dec 12, 2019 Buy $0.90 166,667 150,000 693,682 Dec 16, 2019, 03:10 PM
Taglietti Marco Chief Executive Officer Aug 20, 2019 Buy $1.11 500 555 516,515 Aug 22, 2019, 08:22 AM
Taglietti Marco Chief Executive Officer Aug 21, 2019 Buy $1.11 9,500 10,545 526,015 Aug 22, 2019, 08:22 AM
Taglietti Marco Chief Executive Officer Aug 15, 2019 Buy $1.01 10,015 10,115 516,015 Aug 19, 2019, 08:31 AM
Taglietti Marco Chief Executive Officer Apr 17, 2019 Buy $1.63 25,000 40,750 506,000 Apr 18, 2019, 08:39 AM
Taglietti Marco Chief Executive Officer Jan 10, 2019 Buy $0.69 25,000 17,250 480,000 Jan 14, 2019, 09:04 AM
Taglietti Marco Chief Executive Officer Dec 31, 2018 Buy $0.46 25,000 11,500 455,000 Jan 02, 2019, 11:28 AM
Angulo Gonzalez David Chief Medical Officer Dec 31, 2018 Buy $0.50 12,000 5,951 121,790 Jan 02, 2019, 11:28 AM
Angulo Gonzalez David Chief Medical Officer Sep 06, 2018 Buy $1.27 7,000 8,890 108,790 Sep 10, 2018, 09:09 AM
Taglietti Marco Chief Executive Officer Aug 23, 2018 Buy $1.29 25,000 32,250 429,000 Aug 27, 2018, 08:29 AM
Angulo Gonzalez David Chief Medical Officer Mar 29, 2018 Buy $1.36 6,000 8,160 101,790 Apr 02, 2018, 08:10 AM
Angulo Gonzalez David Chief Medical Officer Mar 08, 2018 Buy $1.39 7,000 9,730 95,790 Mar 12, 2018, 04:43 PM
HASTINGS DAVID C Director Mar 08, 2018 Buy $1.69 11,834 19,999 31,834 Mar 12, 2018, 08:52 AM
Sukenick Scott General Counsel Mar 08, 2018 Buy $1.69 2,959 5,001 2,959 Mar 12, 2018, 08:51 AM
Taglietti Marco Chief Executive Officer Mar 08, 2018 Buy $1.69 100,000 169,000 404,000 Mar 12, 2018, 08:50 AM
Francois Eric Chief Financial Officer Mar 08, 2018 Buy $1.69 5,917 10,000 24,917 Mar 12, 2018, 08:49 AM
Angulo Gonzalez David Chief Medical Officer Mar 08, 2018 Buy $1.69 14,790 24,995 88,790 Mar 12, 2018, 08:48 AM
Taglietti Marco Chief Executive Officer Sep 22, 2017 Buy $2.23 10,000 22,300 303,000 Sep 25, 2017, 04:34 PM
Taglietti Marco Chief Executive Officer Aug 23, 2017 Buy $1.85 4,993 9,237 292,000 Aug 24, 2017, 09:28 AM
Taglietti Marco Chief Executive Officer Aug 22, 2017 Buy $1.61 7 11 287,007 Aug 24, 2017, 09:28 AM
Taglietti Marco Chief Executive Officer Aug 15, 2017 Buy $1.61 10,000 16,100 287,000 Aug 17, 2017, 09:32 AM
Angulo Gonzalez David Chief Medical Officer Aug 11, 2017 Buy $1.55 10,000 15,500 72,000 Aug 14, 2017, 04:29 PM
HASTINGS DAVID C Director Jun 21, 2017 Buy $1.75 20,000 35,000 20,000 Jun 22, 2017, 08:58 AM
Taglietti Marco Chief Executive Officer May 12, 2017 Buy $1.69 25,000 42,250 277,000 May 15, 2017, 08:17 AM
Angulo Gonzalez David Chief Medical Officer May 12, 2017 Buy $1.70 15,000 25,500 62,000 May 15, 2017, 08:17 AM
Taglietti Marco Chief Executive Officer Dec 21, 2016 Buy $3.30 25,000 82,500 251,000 Dec 22, 2016, 06:05 AM
Angulo Gonzalez David Chief Medical Officer Dec 16, 2016 Buy $3.25 4,000 13,000 46,000 Dec 19, 2016, 06:44 AM
Machado Patrick Director Sep 15, 2016 Buy $2.94 40,000 117,600 60,000 Sep 16, 2016, 08:50 AM
Angulo Gonzalez David Chief Medical Officer Jun 30, 2016 Buy $2.23 32,150 71,695 41,000 Jul 01, 2016, 10:31 AM
Angulo Gonzalez David Chief Medical Officer Jun 29, 2016 Buy $2.18 4,800 10,464 8,850 Jul 01, 2016, 10:31 AM
Machado Clarence Patrick Director Jun 24, 2016 Buy $2.39 20,000 47,800 20,000 Jun 28, 2016, 07:53 AM
Francois Eric Chief Financial Officer Jun 24, 2016 Buy $2.39 15,000 35,850 15,000 Jun 28, 2016, 07:53 AM
Taglietti Marco Chief Executive Officer Jun 24, 2016 Buy $2.39 100,000 239,000 225,000 Jun 28, 2016, 07:53 AM
Macdonald Guy Director Jun 24, 2016 Buy $2.39 40,000 95,600 40,000 Jun 28, 2016, 07:52 AM
Taglietti Marco Chief Executive Officer May 25, 2016 Buy $3.20 246 787 125,000 May 27, 2016, 03:54 PM
HANHAM ANN Director May 25, 2016 Buy $3.64 4,225 15,379 4,225 May 27, 2016, 01:53 PM
Taglietti Marco Chief Executive Officer May 25, 2016 Buy $3.26 5,754 18,758 124,754 May 27, 2016, 09:16 AM
Taglietti Marco Chief Executive Officer May 24, 2016 Buy $3.37 5,500 18,535 119,000 May 25, 2016, 09:00 AM
Taglietti Marco Chief Executive Officer May 20, 2016 Buy $3.14 4,500 14,130 110,500 May 24, 2016, 09:30 AM
Taglietti Marco Chief Executive Officer May 23, 2016 Buy $3.15 3,000 9,450 113,500 May 24, 2016, 09:30 AM
Taglietti Marco Chief Executive Officer May 19, 2016 Buy $3.07 6,000 18,420 106,000 May 20, 2016, 08:06 AM
Taglietti Marco Chief Executive Officer Nov 24, 2015 Buy $6.80 7,733 52,584 100,000 Nov 24, 2015, 05:47 PM
Taglietti Marco Chief Executive Officer Nov 23, 2015 Buy $6.79 15,000 101,850 92,267 Nov 24, 2015, 05:47 PM
Angulo Gonzalez David Chief Medical Officer Sep 15, 2015 Buy $7.00 3,000 21,000 3,000 Sep 18, 2015, 04:59 PM
Taglietti Marco Chief Executive Officer Aug 31, 2015 Buy $7.82 25,000 195,500 77,267 Sep 02, 2015, 09:51 PM
Taglietti Marco Chief Executive Officer Aug 28, 2015 Buy $7.15 400 2,860 52,267 Aug 31, 2015, 06:52 PM
Taglietti Marco Chief Executive Officer Aug 27, 2015 Buy $7.07 1,867 13,200 51,867 Aug 31, 2015, 06:52 PM
Taglietti Marco Chief Executive Officer Aug 26, 2015 Buy $6.98 25,000 174,500 50,000 Aug 27, 2015, 04:56 PM
Taglietti Marco Chief Executive Officer Aug 25, 2015 Buy $7.15 25,000 178,800 25,000 Aug 27, 2015, 04:56 PM
F.C.P.R. Genavent 10% Owner May 07, 2014 Buy $10.00 10,000 100,000 237,598 May 09, 2014, 02:36 PM
F.C.P.R. Genavent 10% Owner May 07, 2014 Option Exercise $0.20 14,003 2,801 14,003 May 09, 2014, 02:36 PM
Arthaud Laurent Director May 07, 2014 Option Exercise $0.20 290 58 4,028 May 08, 2014, 09:43 PM
FCPR Biotechnology Fund 10% Owner May 07, 2014 Buy $10.00 50,000 500,000 295,077 May 08, 2014, 09:32 PM
FCPR Biotechnology Fund 10% Owner May 07, 2014 Option Exercise $0.20 36,500 7,300 36,500 May 08, 2014, 09:32 PM
Nothias Jean-Yves Director May 07, 2014 Buy $10.00 50,000 500,000 295,077 May 08, 2014, 09:31 PM
Nothias Jean-Yves Director May 07, 2014 Option Exercise $0.20 36,500 7,300 36,500 May 08, 2014, 09:31 PM
ALTA BIOPHARMA PARTNERS II LP 10% Owner May 07, 2014 Buy $10.00 31,934 319,340 45,736 May 08, 2014, 09:29 PM
ALTA BIOPHARMA PARTNERS II LP 10% Owner May 07, 2014 Buy $10.00 868,066 8,680,660 1,240,575 May 08, 2014, 09:29 PM
ALTA BIOPHARMA PARTNERS II LP 10% Owner May 07, 2014 Option Exercise $0.20 91,556 18,311 91,556 May 08, 2014, 09:29 PM
ALTA BIOPHARMA PARTNERS II LP 10% Owner May 07, 2014 Option Exercise $0.20 3,381 676 3,381 May 08, 2014, 09:29 PM
KIRBY PAMELA J Director May 07, 2014 Option Exercise $0.20 12,745 2,549 12,745 May 08, 2014, 09:28 PM
Ventech Capital II 10% Owner May 07, 2014 Buy $10.00 28,000 280,000 414,211 May 08, 2014, 09:25 PM
Ventech Capital II 10% Owner May 07, 2014 Option Exercise $0.20 71,714 14,343 71,714 May 08, 2014, 09:25 PM
Ribeill Yves J President and CEO May 07, 2014 Option Exercise $0.20 595 119 595 May 08, 2014, 09:24 PM
Langlois Patrick Director May 07, 2014 Option Exercise $0.20 5,251 1,050 26,785 May 08, 2014, 09:23 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Taglietti Marco Chief Executive Officer 04/26/2022 225,000
Sukenick Scott General Counsel 04/26/2022 10,500
PERCEPTIVE ADVISORS LLC 10% Owner 01/22/2021 2,629,781
PERCEPTIVE ADVISORS LLC 10% Owner 01/21/2021 701,100
PERCEPTIVE ADVISORS LLC 10% Owner 01/20/2021 1,374,550
Tinmouth Brian Philippe Director 12/21/2020 50,000
Taglietti Marco Chief Executive Officer 12/21/2020 250,000
Sukenick Scott General Counsel 12/21/2020 10,000
Macdonald Guy Director 12/21/2020 50,000
HANHAM ANN Director 12/21/2020 20,000
GILMAN STEVEN C Director 12/21/2020 25,000
Francois Eric Chief Financial Officer 12/21/2020 3,750
ANIDO ARMANDO Director 12/21/2020 31,250
Angulo Gonzalez David Chief Medical Officer 12/21/2020 10,000
Sukenick Scott General Counsel 11/25/2020 17,795
Sukenick Scott General Counsel 02/15/2020 7,673
Francois Eric Chief Financial Officer 11/25/2020 23,699
Francois Eric Chief Financial Officer 02/15/2020 9,594
Angulo Gonzalez David Chief Medical Officer 11/25/2020 29,440
Angulo Gonzalez David Chief Medical Officer 02/15/2020 11,515
Taglietti Marco Chief Executive Officer 12/12/2019 150,000
Taglietti Marco Chief Executive Officer 08/20/2019 555
Taglietti Marco Chief Executive Officer 08/21/2019 10,545
Taglietti Marco Chief Executive Officer 08/15/2019 10,115
Taglietti Marco Chief Executive Officer 04/17/2019 40,750
Taglietti Marco Chief Executive Officer 01/10/2019 17,250
Taglietti Marco Chief Executive Officer 12/31/2018 11,500
Angulo Gonzalez David Chief Medical Officer 12/31/2018 5,951
Angulo Gonzalez David Chief Medical Officer 09/06/2018 8,890
Taglietti Marco Chief Executive Officer 08/23/2018 32,250
Angulo Gonzalez David Chief Medical Officer 03/29/2018 8,160
Angulo Gonzalez David Chief Medical Officer 03/08/2018 9,730
HASTINGS DAVID C Director 03/08/2018 19,999
Sukenick Scott General Counsel 03/08/2018 5,001
Taglietti Marco Chief Executive Officer 03/08/2018 169,000
Francois Eric Chief Financial Officer 03/08/2018 10,000
Angulo Gonzalez David Chief Medical Officer 03/08/2018 24,995
Taglietti Marco Chief Executive Officer 09/22/2017 22,300
Taglietti Marco Chief Executive Officer 08/23/2017 9,237
Taglietti Marco Chief Executive Officer 08/22/2017 11
Taglietti Marco Chief Executive Officer 08/15/2017 16,100
Angulo Gonzalez David Chief Medical Officer 08/11/2017 15,500
HASTINGS DAVID C Director 06/21/2017 35,000
Taglietti Marco Chief Executive Officer 05/12/2017 42,250
Angulo Gonzalez David Chief Medical Officer 05/12/2017 25,500
Taglietti Marco Chief Executive Officer 12/21/2016 82,500
Angulo Gonzalez David Chief Medical Officer 12/16/2016 13,000
Machado Patrick Director 09/15/2016 117,600
Angulo Gonzalez David Chief Medical Officer 06/30/2016 71,695
Angulo Gonzalez David Chief Medical Officer 06/29/2016 10,464
Machado Clarence Patrick Director 06/24/2016 47,800
Francois Eric Chief Financial Officer 06/24/2016 35,850
Taglietti Marco Chief Executive Officer 06/24/2016 239,000
Macdonald Guy Director 06/24/2016 95,600
Taglietti Marco Chief Executive Officer 05/25/2016 787
HANHAM ANN Director 05/25/2016 15,379
Taglietti Marco Chief Executive Officer 05/25/2016 18,758
Taglietti Marco Chief Executive Officer 05/24/2016 18,535
Taglietti Marco Chief Executive Officer 05/20/2016 14,130
Taglietti Marco Chief Executive Officer 05/23/2016 9,450
Taglietti Marco Chief Executive Officer 05/19/2016 18,420
Taglietti Marco Chief Executive Officer 11/24/2015 52,584
Taglietti Marco Chief Executive Officer 11/23/2015 101,850
Angulo Gonzalez David Chief Medical Officer 09/15/2015 21,000
Taglietti Marco Chief Executive Officer 08/31/2015 195,500
Taglietti Marco Chief Executive Officer 08/28/2015 2,860
Taglietti Marco Chief Executive Officer 08/27/2015 13,200
Taglietti Marco Chief Executive Officer 08/26/2015 174,500
Taglietti Marco Chief Executive Officer 08/25/2015 178,800
F.C.P.R. Genavent 10% Owner 05/07/2014 100,000
F.C.P.R. Genavent 10% Owner 05/07/2014 2,801
Arthaud Laurent Director 05/07/2014 58
FCPR Biotechnology Fund 10% Owner 05/07/2014 500,000
FCPR Biotechnology Fund 10% Owner 05/07/2014 7,300
Nothias Jean-Yves Director 05/07/2014 500,000
Nothias Jean-Yves Director 05/07/2014 7,300
ALTA BIOPHARMA PARTNERS II LP 10% Owner 05/07/2014 319,340
ALTA BIOPHARMA PARTNERS II LP 10% Owner 05/07/2014 8,680,660
ALTA BIOPHARMA PARTNERS II LP 10% Owner 05/07/2014 18,311
ALTA BIOPHARMA PARTNERS II LP 10% Owner 05/07/2014 676
KIRBY PAMELA J Director 05/07/2014 2,549
Ventech Capital II 10% Owner 05/07/2014 280,000
Ventech Capital II 10% Owner 05/07/2014 14,343
Ribeill Yves J President and CEO 05/07/2014 119
Langlois Patrick Director 05/07/2014 1,050
Load More Insider Transactions